Concurrent MPL515 and JAK2V617F mutations in myelofibrosis: chronology of clonal emergence and changes in mutant allele burden over time

作者: Terra L. Lasho , Animesh Pardanani , Rebecca F. McClure , Ruben A. Mesa , Ross L. Levine

DOI: 10.1111/J.1365-2141.2006.06348.X

关键词:

摘要: MPLW515L/K and JAK2V617F can co-exist in myelofibrosis with myeloid metaplasia (MMM). The chronology of clonal emergence was studied three such cases using serially stored bone marrow. At diagnosis, a major MPL515 mutant clone accompanied by minor all instances. 25 time points over period 4-8 years, allele burden fluctuated but remained high for low JAK2V617F. We conclude that are both early events MMM burden, rather than the mere presence these mutations, might be relevant to phenotypic variation myeloproliferative disorders.

参考文章(10)
JAK2 mutations in myeloproliferative disorders [4] (multiple letters) The New England Journal of Medicine. ,vol. 353, pp. 1416- 1417 ,(2005) , 10.1056/NEJMC051878
Linda M. Scott, Mike A. Scott, Peter J. Campbell, Anthony R. Green, Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia Blood. ,vol. 108, pp. 2435- 2437 ,(2006) , 10.1182/BLOOD-2006-04-018259
Terra L. Lasho, Ruben Mesa, D. Gary Gilliland, Ayalew Tefferi, Mutation studies in CD3+, CD19+ and CD34+ cell fractions in myeloproliferative disorders with homozygous JAK2V617F in granulocytes British Journal of Haematology. ,vol. 130, pp. 797- 799 ,(2005) , 10.1111/J.1365-2141.2005.05682.X
Chloé James, Valérie Ugo, Jean-Pierre Le Couédic, Judith Staerk, François Delhommeau, Catherine Lacout, Loïc Garçon, Hana Raslova, Roland Berger, Annelise Bennaceur-Griscelli, Jean Luc Villeval, Stefan N. Constantinescu, Nicole Casadevall, William Vainchenker, A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera Nature. ,vol. 434, pp. 1144- 1148 ,(2005) , 10.1038/NATURE03546
Eric Lippert, Marjorie Boissinot, Robert Kralovics, François Girodon, Irène Dobo, Vincent Praloran, Nathalie Boiret-Dupré, Radek C. Skoda, Sylvie Hermouet, The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera Blood. ,vol. 108, pp. 1865- 1867 ,(2006) , 10.1182/BLOOD-2006-01-013540
Gerlinde Wernig, Thomas Mercher, Rachel Okabe, Ross L. Levine, Benjamin H. Lee, D. Gary Gilliland, Expression of Jak2V617F causes a polycythemia vera-like disease with associated myelofibrosis in a murine bone marrow transplant model. Blood. ,vol. 107, pp. 4274- 4281 ,(2006) , 10.1182/BLOOD-2005-12-4824
Yana Pikman, Benjamin H Lee, Thomas Mercher, Elizabeth McDowell, Benjamin L Ebert, Maricel Gozo, Adam Cuker, Gerlinde Wernig, Sandra Moore, Ilene Galinsky, Daniel J DeAngelo, Jennifer J Clark, Stephanie J Lee, Todd R Golub, Martha Wadleigh, D. Gary Gilliland, Ross L Levine, MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia. PLOS Medicine. ,vol. 3, ,(2006) , 10.1371/JOURNAL.PMED.0030270
Animesh D. Pardanani, Ross L. Levine, Terra Lasho, Yana Pikman, Ruben A. Mesa, Martha Wadleigh, David P. Steensma, Michelle A. Elliott, Alexandra P. Wolanskyj, William J. Hogan, Rebecca F. McClure, Mark R. Litzow, D. Gary Gilliland, Ayalew Tefferi, MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients Blood. ,vol. 108, pp. 3472- 3476 ,(2006) , 10.1182/BLOOD-2006-04-018879